Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
1.51(c) 1.61(c) 1.7(c) 1.66(c) 1.645 Last
3 632 658 1 580 528 2 665 727 969 522 253 215 Volume
-6.21% +6.62% +5.59% -2.35% -0.90% Change
More quotes
Financials ($)
Sales 2015 16,1 M
EBIT 2015 -44,8 M
Net income 2015 -46,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 27,5 M
EBIT 2016 -34,6 M
Net income 2016 -34,5 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 16,7x
Capi. / Sales 2016 9,78x
Capitalization 268 M
More Financials
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.Its development portfolio ranges from mid to late stage clinical assets which include... 
Sector
Pharmaceuticals
Calendar
08/17Earnings Release
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
07/29 Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
07/29 GALENA BIOPHARMA : to Report Second Quarter Financial Results on Thursday, Augus..
07/28 GALENA BIOPHARMA : to Report Second Quarter Financial Results on Thursday, Augus..
06/24 GALENA BIOPHARMA : Change in Directors or Principal Officers, Other Events (form..
06/15 Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Phase 2 Da..
06/08 GALENA BIOPHARMA : GALE) is Trading Higher on Unusual Volume for June 08
05/29 GALENA BIOPHARMA : to Present at the Sachs Immuno-Oncology BD&L and Investment F..
05/28 Galena Biopharma to Present at the Sachs Immuno-Oncology BD&L and Investment ..
More news
Sector news : Pharmaceuticals - NEC
08:46aDJMERCK : WHO Says Ebola Vaccine Effective in African Trial
08:45aDJWHO Says Ebola Vaccine Effective in African Trial -- Update
08:36a ABBOTT LABORATORIES : Labs to Acquire Remaining Stake in Tendyne for USD250 Mill..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/30 Tesaro inks license deal with Jiangsu Hengrui for exclusive distribution of r..
07/30 PREMARKET BIOTECH DIGEST : Familial Hypercholesterolemia, Dynavax BLA Track, Ear..
07/29 Galena Bio launches Zuplenz in the U.S.; shares up 5%
07/20 BIOTECH WEEKLY : 7 Stock-Specific Reasons Why You Shouldn't Buy That Speculative..
06/15 Galena's anagrelide shows encouraging results in Phase 2 study


Comments 
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions